Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome
- 1 October 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Molecular and Cellular Biology
- Vol. 41 (10), e0035221
- https://doi.org/10.1128/mcb.00352-21
Abstract
Sjögren–Larsson syndrome (SLS) is an inherited neurocutaneous disorder whose causative gene encodes the fatty aldehyde dehydrogenase ALDH3A2. To date, the detailed molecular mechanism of the skin pathology of SLS has remained largely unclear. We generated double knockout (DKO) mice for Aldh3a2 and its homolog Aldh3b2 (a pseudogene in humans). These mice showed hyperkeratosis and reduced fatty aldehyde dehydrogenase activity and skin barrier function. The levels of ω-O-acylceramides (acylceramides), which are specialized ceramides essential for skin barrier function, in the epidermis of DKO mice were about 60% of those in wild type mice. In the DKO mice, levels of acylceramide precursors (ω-hydroxy ceramides and triglycerides) were increased, suggesting that the final step of acylceramide production was inhibited. A decrease in acylceramide levels was also observed in human immortalized keratinocytes lacking ALDH3A2. Differentiated keratinocytes prepared from the DKO mice exhibited impaired long-chain base metabolism. Based on these results, we propose that the long-chain-base–derived fatty aldehydes that accumulate in DKO mice and SLS patients attack and inhibit the enzyme involved in the final step of acylceramide. Our findings provide insight into the pathogenesis of the skin symptoms of SLS, i.e., decreased acylceramide production, and its molecular mechanism.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP20gm0910002h0006)
- MEXT | Japan Society for the Promotion of Science (JP18H03976)
This publication has 52 references indexed in Scilit:
- The role of sphingolipid metabolism in cutaneous permeabilitybarrier formationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014
- Altered lipid profiles in the stratum corneum of Sjögren-Larsson syndromeJournal of Dermatological Science, 2011
- Central nervous system dysfunction in a mouse model of Fa2h deficiencyGlia, 2011
- The role of fatty aldehyde dehydrogenase in epidermal structure and functionDermato-Endocrinology, 2011
- Fatty acid 2-Hydroxylation in mammalian sphingolipid biologyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Absence of 2-Hydroxylated Sphingolipids Is Compatible with Normal Neural Development But Causes Late-Onset Axon and Myelin Sheath DegenerationJournal of Neuroscience, 2008
- Sjögren–Larsson syndrome: Molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiencyMolecular Genetics and Metabolism, 2007
- The skin barrier in healthy and diseased stateBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman SyndromeCell Metabolism, 2006
- A mammalian fatty acid hydroxylase responsible for the formation of α-hydroxylated galactosylceramide in myelinBiochemical Journal, 2005